The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Leandro Boer, MD, PhD, VP, US general medicines, Amgen, discusses new real-world data showing that most high-risk ...

What was once considered a competitive advantage for forward-thinking commercial teams has now become essential for success ...

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at ...

President Trump announced a plan to reduce prescription drug prices by implementing a most-favored-nation policy with the ...

Armando Castro, partner, emerging companies, venture capital, Lowenstein Sandler, explains how repurposing GLP-1s and ...

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society ...

Stricter regulations on a fragmented media landscape is forcing the industry to rethink marketing.

A successful M&A outcome is contingent upon a deep understanding of the regulatory and scientific fundamentals that underpin ...

The order pushes drug companies to reduce drug prices in the United States to fall in line with other countries around the ...

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...